Protalix Biotherapeutics Inc
PLX2.220USD
-0.160-6.72%
收盤 11/06, 16:00（美東）報價延遲15分鐘
177.01M總市值
28.21本益比TTM
關於 Protalix Biotherapeutics Inc 公司
Protalix BioTherapeutics, Inc. 是一家生物製藥公司。該公司專注於通過其專有的植物細胞表達系統 ProCellEx 表達重組治療蛋白的開發和商業化。此外，該公司正在開發用於治療嚴重痛風的聚乙二醇化尿酸酶或 PRX-115、用於治療 NET 相關疾病的長效 (LA) DNase I 或 PRX-119，以及其他技術和臨牀前資產。其產品 Elelyso 是一種用於治療戈謝病患者的酶替代療法 (ERT)。其 ProCellEx 平臺用於製造其已獲批和上市的產品以及 PRX-115 和 PRX-119。PRX-115 是一種植物細胞表達的重組聚乙二醇化尿酸酶（尿酸氧化酶），這是一種正在開發的化學修飾酶，可用於治療嚴重痛風。 PRX-119 是一種植物細胞表達的聚乙二醇化重組人 DNase I 候選產品。
Protalix Biotherapeutics Inc簡介
公司代碼PLX
公司名稱Protalix Biotherapeutics Inc
上市日期Sep 06, 2010
CEOMr. Dror Bashan
員工數量207
證券類型Ordinary Share
年結日Sep 06
公司地址2 University Plaza
城市HACKENSACK
上市交易所Euronext Paris
國家United States of America
郵編07601
電話12016969345
網址https://protalix.com/
公司代碼PLX
上市日期Sep 06, 2010
CEOMr. Dror Bashan
Protalix Biotherapeutics Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Dror Bashan
Mr. Dror Bashan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.28M
--
Dr. Aharon Schwartz, Ph.D.
Dr. Aharon Schwartz, Ph.D.
Independent Director
Independent Director
303.00K
+74.14%
Mr. Yaron Naos
Mr. Yaron Naos
Senior Vice President - Operations
Senior Vice President - Operations
207.30K
--
Ms. Gwen A. Melincoff
Ms. Gwen A. Melincoff
Independent Director
Independent Director
40.00
--
Dr. Pol F. Boudes, M.D.
Dr. Pol F. Boudes, M.D.
Independent Director
Independent Director
40.00
--
Mr. Mike Moyer
Mr. Mike Moyer
Investor Relations
Investor Relations
--
--
Mr. Amos Bar Shalev
Mr. Amos Bar Shalev
Independent Director
Independent Director
--
--
Dr. Shmuel (Muli) Ben-Zvi, Ph.D.
Dr. Shmuel (Muli) Ben-Zvi, Ph.D.
Independent Director
Independent Director
--
--
Dr. Eliot Richard Forster, Ph.D.
Dr. Eliot Richard Forster, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Gilad Mamlok
Mr. Gilad Mamlok
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Dror Bashan
Mr. Dror Bashan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.28M
--
Dr. Aharon Schwartz, Ph.D.
Dr. Aharon Schwartz, Ph.D.
Independent Director
Independent Director
303.00K
+74.14%
Mr. Yaron Naos
Mr. Yaron Naos
Senior Vice President - Operations
Senior Vice President - Operations
207.30K
--
Ms. Gwen A. Melincoff
Ms. Gwen A. Melincoff
Independent Director
Independent Director
40.00
--
Dr. Pol F. Boudes, M.D.
Dr. Pol F. Boudes, M.D.
Independent Director
Independent Director
40.00
--
Mr. Mike Moyer
Mr. Mike Moyer
Investor Relations
Investor Relations
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 10月23日 週四
更新時間: 10月23日 週四
持股股東
股東類型
持股股東
持股股東
佔比
HIR Investments Ltd
5.91%
BlackRock Institutional Trust Company, N.A.
3.77%
Bashan (Dror)
2.86%
Renaissance Technologies LLC
2.03%
Geode Capital Management, L.L.C.
1.04%
其他
84.40%
持股股東
持股股東
佔比
HIR Investments Ltd
5.91%
BlackRock Institutional Trust Company, N.A.
3.77%
Bashan (Dror)
2.86%
Renaissance Technologies LLC
2.03%
Geode Capital Management, L.L.C.
1.04%
其他
84.40%
股東類型
持股股東
佔比
Investment Advisor
8.56%
Corporation
5.91%
Individual Investor
4.33%
Investment Advisor/Hedge Fund
3.78%
Hedge Fund
2.19%
Research Firm
0.32%
Pension Fund
0.14%
Venture Capital
0.09%
Bank and Trust
0.09%
其他
74.59%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
176
12.12M
15.21%
+1.33M
2025Q2
183
18.79M
23.60%
+3.26M
2025Q1
182
19.45M
25.30%
+4.26M
2024Q4
169
15.65M
21.26%
-1.03M
2024Q3
162
14.11M
19.17%
-5.41M
2024Q2
163
16.36M
22.25%
-4.44M
2024Q1
143
16.45M
23.43%
-4.40M
2023Q4
145
17.20M
24.67%
-3.21M
2023Q3
142
16.45M
24.08%
-6.46M
2023Q2
132
16.38M
24.76%
-4.13M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
HIR Investments Ltd
4.71M
5.91%
--
--
Apr 30, 2025
BlackRock Institutional Trust Company, N.A.
3.00M
3.77%
+2.84M
+1741.73%
Jun 30, 2025
Bashan (Dror)
2.28M
2.86%
--
--
Apr 30, 2025
Renaissance Technologies LLC
1.62M
2.03%
+426.05K
+35.83%
Jun 30, 2025
Geode Capital Management, L.L.C.
826.33K
1.04%
+826.33K
--
Jun 30, 2025
Northern Trust Global Investments Limited
689.88K
0.87%
+6.58K
+0.96%
Jun 30, 2025
Rubin (Eyal)
660.91K
0.83%
+90.91K
+15.95%
Apr 30, 2025
Stratos Wealth Partners, Ltd.
350.00K
0.44%
+3.60K
+1.04%
Jun 30, 2025
Connor, Clark & Lunn Investment Management Ltd.
496.22K
0.62%
+13.34K
+2.76%
Jun 30, 2025
The Vanguard Group, Inc.
484.80K
0.61%
+484.80K
--
Jun 30, 2025
查看更多
持股ETF
更新時間: 21 小時前
更新時間: 21 小時前
機構名稱
佔比
iShares Micro-Cap ETF
0.03%
ProShares UltraPro Russell2000
0.01%
Franklin US Small Cap Multifactor Index ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Global X Russell 2000 ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
ProShares Hedge Replication ETF
0.01%
DFA Dimensional US Sustainability Core 1 ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
查看更多
iShares Micro-Cap ETF
佔比0.03%
ProShares UltraPro Russell2000
佔比0.01%
Franklin US Small Cap Multifactor Index ETF
佔比0.01%
iShares Russell 2000 Growth ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0.01%
Global X Russell 2000 ETF
佔比0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
佔比0.01%
ProShares Hedge Replication ETF
佔比0.01%
DFA Dimensional US Sustainability Core 1 ETF
佔比0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
